Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis.
Kurz
Paul A
PA
Ohio State University, Havener Eye Institute, 915 Olentangy River Road, Columbus, OH 43212, USA. paul.kurz@osumc.edu
Chheda
Lena V
LV
Kurz
Daryl E
DE
D000287:Administration, Topical; D002386:Cataract / Q000139:chemically induced; D002648:Child; D004655:Emulsions; D005477:Fluprednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D009798:Ocular Hypertension / Q000139:chemically induced; D015868:Pars Planitis / Q000188:drug therapy*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D016896:Treatment Outcome; D014792:Visual Acuity; D015430:Weight Gain / Q000187:drug effects
D004655:Emulsions; D005938:Glucocorticoids; D005477:Fluprednisolone; C015808:difluprednate; D011241:Prednisone